Dubai Investments, a number one funding firm listed on the Dubai Monetary Market within the UAE, by its wholly owned subsidiary Globalpharma – UAE’s main pharmaceutical producer, has signed Memorandum of Understanding (MoU) with Angola’s Ministry of Well being to determine a pharmaceutical manufacturing facility in DIP Angola.
The MoU displays the strengthened bilateral relations highlighted through the latest UAE delegation go to to Angola, led by His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates and Ruler of Abu Dhabi, underscoring each nations’ dedication to advancing collaboration and sustainable progress throughout key sectors.
As a part of the MoU, Globalpharma will associate with Angola’s Ministry of Well being to drive native manufacturing of medicines. The initiative is anticipated to create a whole bunch of jobs, improve healthcare self-sufficiency, and scale back reliance on imported medical merchandise — a key milestone in strengthening Angola’s healthcare ecosystem.
The MoU was signed by Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, and Dr. Nídia da Silva Jorge Saiundo, standing in illustration for the Ministry of Well being, Angola, reinforcing the shared dedication to sustainable healthcare improvement within the nation.
Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, mentioned: “This settlement marks greater than a partnership — it represents a shared imaginative and prescient for the way forward for Angola’s healthcare panorama. Dubai Investments believes that sustainable progress comes from empowering nations to unlock their very own potential. By aligning with Angola’s ambitions to turn into a regional hub for healthcare, Dubai Investments is investing not simply in a undertaking by this facility in DIP Angola, however within the foundations of long-term healthcare prosperity. This strategic collaboration displays the Group’s dedication to constructing bridges between markets, accelerating Africa’s industrialization, and contributing to a extra diversified and resilient world financial system.”
With over 20 years of experience, Globalpharma has established itself as a number one producer of high-quality generic and branded medicines throughout key therapeutic areas, together with cardiovascular, anti-infective, gastrointestinal, and ache administration. The corporate’s state-of-the-art manufacturing services are cGMP-certified and authorized by well being authorities throughout the GCC, Levant, Africa, and CIS areas.
Hon. Sílvia Paula Valentim Lutucuta, Minister of Well being of Angola commented: “This collaboration with DIP Angola and Globalpharma will strengthen Angola’s native manufacturing of important medicines, reinforcing our healthcare system and guaranteeing higher entry to high- high quality medical merchandise. By boosting home manufacturing, we’re advancing towards self-sufficiency and bettering the resilience of our healthcare sector.”
The MoUs will formalize the assist and facilitation prolonged by the ministry for the profitable implementation of DIP Angola’s initiatives. The Ministry of Well being will coordinate with related authorities our bodies to expedite the issuance of licenses, permits, and regulatory approvals,
in addition to facilitate entry to accessible tax incentives, exemptions, and funding advantages, in accordance with nationwide legal guidelines and funding promotion rules.
Dubai Investments has been steadily increasing its footprint in Angola over the past two years by the event of DIP Angola — the nation’s first built-in financial zone. Modeled on the success of Dubai Investments Park within the UAE, an built-in mixed-use improvement that mixes residential, business, and industrial elements, DIP Angola is envisioned as a catalyst for Angola’s financial diversification, industrialization, and job creation.